GlassScriptPhysician profile
Luke S Johnson
NPI 1124361233
$671.66
in general payments reported to CMS, 2019-2025
12 companies · $45.61 in 2025
The $45.61 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.74 · 2020: $185 · 2021: $14.09 · 2023: $166 · 2024: $246 · 2025: $45.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $457.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prugen, INC. Pharmaceuticals | $185.00 | 2020 | |
| Novartis Pharmaceuticals Corporation | $119.51 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $117.15 | 2023 | Dupixent |
| Ucb, INC. | $64.33 | 2024 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $39.53 | 2024 | |
| Arcutis Biotherapeutics, INC. | $31.64 | 2024 | Zoryve |
| Pfizer INC. | $26.88 | 2025 | |
| Acadia Pharmaceuticals INC | $23.46 | 2023 | Nuplazid |
| Kerecis Limited | $18.73 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Dermavant Sciences, INC. | $16.60 | 2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.74 | 2019 | |
| Pierre Fabre Pharmaceuticals, INC. | $14.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.